GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CompuGroup Medical SE & Co KgaA (XTER:COP) » Definitions » Market Cap

CompuGroup Medical SE KgaA (XTER:COP) Market Cap : €1,172 Mil (As of Mar. 28, 2025)


View and export this data going back to 2007. Start your Free Trial

What is CompuGroup Medical SE KgaA Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). CompuGroup Medical SE KgaA's share price for the quarter that ended in Dec. 2024 was €21.76. CompuGroup Medical SE KgaA's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 52 Mil. Therefore, CompuGroup Medical SE KgaA's market cap for the quarter that ended in Dec. 2024 was €1,126 Mil.

CompuGroup Medical SE KgaA's quarterly market cap declined from Jun. 2024 (€1,231 Mil) to Sep. 2024 (€736 Mil) but then increased from Sep. 2024 (€736 Mil) to Dec. 2024 (€1,126 Mil).

CompuGroup Medical SE KgaA's annual market cap increased from Dec. 2022 (€1,879 Mil) to Dec. 2023 (€1,980 Mil) but then declined from Dec. 2023 (€1,980 Mil) to Dec. 2024 (€1,126 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. CompuGroup Medical SE KgaA's Enterprise Value for Today is €1,945 Mil.


CompuGroup Medical SE KgaA Market Cap Historical Data

The historical data trend for CompuGroup Medical SE KgaA's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CompuGroup Medical SE KgaA Market Cap Chart

CompuGroup Medical SE KgaA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,223.57 3,723.35 1,879.42 1,979.71 1,125.75

CompuGroup Medical SE KgaA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,979.71 1,487.57 1,231.29 735.67 1,125.75

Competitive Comparison of CompuGroup Medical SE KgaA's Market Cap

For the Health Information Services subindustry, CompuGroup Medical SE KgaA's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CompuGroup Medical SE KgaA's Market Cap Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CompuGroup Medical SE KgaA's Market Cap distribution charts can be found below:

* The bar in red indicates where CompuGroup Medical SE KgaA's Market Cap falls into.


;
;

CompuGroup Medical SE KgaA Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

CompuGroup Medical SE KgaA's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=€21.76*51.735
=€1,126

CompuGroup Medical SE KgaA's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=€21.76*51.735
=€1,126

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CompuGroup Medical SE KgaA  (XTER:COP) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


CompuGroup Medical SE KgaA Market Cap Related Terms

Thank you for viewing the detailed overview of CompuGroup Medical SE KgaA's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


CompuGroup Medical SE KgaA Business Description

Traded in Other Exchanges
Address
Maria Trost 21, Koblenz, DEU, 56070
CompuGroup Medical SE & Co KgaA provides electronic health solutions to healthcare providers through the following segments: Ambulatory information systems, Pharmacy information systems, and Hospital information systems. The Ambulatory information systems segment, which generates maximum revenue, focuses on developing and selling practice management software for registered physicians and medical care centers. This segment offers comprehensive end-to-end solutions that cover all essential clinical, administrative, and billing functions. In addition, its portfolio includes data-driven products, software interfaces for information exchange, medical decision support tools, and pharmaceutical and therapy databases, among other solutions. The company mainly operates in the U.S. and Europe.
Executives
Daniela Hommel CFO, Managing director of the general partner of the issuer
Michael Rauch Managing director of the general partner of the issuer
Emanuele Mugnani Managing director of the general partner of the issuer
Frank Gotthardt Chairman of Administrative Board of CompuGroup Medical Management SE
Prof. (apl.) Dr. Med Daniel Gotthardt Member of the Administrative Board of CompuGroup Medical Management SE
Hannes Reichl Managing director of the general partner of the issuer
Dr. Eckart Pech Managing director of the general partner of the issuer
Dr. Dirk Wössner CEO, Managing director of the general partner of the issuer
Dr. Ralph Körfgen Managing director of the general partner of the issuer